Breaking News Instant updates and real-time market news.

ICE

IntercontinentalExchange

$132.94 /

-0.745 (-0.56%)

07:47
10/28/21
10/28
07:47
10/28/21
07:47

IntercontinentalExchange declares 33c per share dividend, up 10% from Q420

Intercontinental Exchang announced a 33c per share dividend for the fourth quarter of 2021, which is up 10% from the 30c per share dividend paid in the fourth quarter of 2020. The cash dividend is payable on December 31, 2021 to stockholders of record as of December 17, 2021. The ex-dividend date is December 16, 2021.

  • 28

    Oct

  • 30

    Nov

  • 05

    Nov

ICE IntercontinentalExchange
$132.94 /

-0.745 (-0.56%)

10/26/21 Piper Sandler
IntercontinentalExchange should have rallied 4% yesterday, says Piper Sandler
10/25/21
Fly Intel: Top five analyst initiations
10/25/21 Jefferies
IntercontinentalExchange resumed with a Buy at Jefferies
10/19/21 Citi
IntercontinentalExchange price target raised to $155 from $150 at Citi

TODAY'S FREE FLY STORIES

Recommendations
Zscaler price target raised to $400 from $385 at Mizuho » 06:47
12/01/21
12/01
06:47
12/01/21
06:47
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Mizuho analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

06:30 Today BTIG
Zscaler price target raised to $439 from $401 at BTIG
06:14 Today JMP Securities
Zscaler price target raised to $400 from $330 at JMP Securities
06:03 Today Piper Sandler
Zscaler price target raised to $365 from $285 at Piper Sandler
11/29/21 Needham
Zscaler price target raised to $390 from $345 at Needham
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Hot Stocks
Sanofi confirms Vaccines mid-term view of mid-to-high single-digit sales growth » 06:47
12/01/21
12/01
06:47
12/01/21
06:47
SNY

Sanofi

$47.61 /

-0.6 (-1.24%)

Sanofi will host a hybrid…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

11/01/21 HSBC
Sanofi upgraded to Buy from Hold at HSBC
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

Recommendations
Cytokinetics price target raised to $54 from $45 at Mizuho » 06:46
12/01/21
12/01
06:46
12/01/21
06:46
CYTK

Cytokinetics

$39.30 /

+0.51 (+1.31%)

Mizuho analyst Salim Syed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
10/04/21 Piper Sandler
Cytokinetics set to make commercial impact, says Piper Sandler
CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

  • 21
    Jul
CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

Downgrade
Fortescue Metals downgraded to Neutral from Buy at Citi » 06:45
12/01/21
12/01
06:45
12/01/21
06:45
FSUGY

Fortescue Metals

$24.36 /

-0.95 (-3.75%)

Citi analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSUGY Fortescue Metals
$24.36 /

-0.95 (-3.75%)

09/17/21 UBS
Fortescue Metals downgraded to Sell from Neutral at UBS
09/09/21 Citi
Fortescue Metals upgraded to Buy from Neutral at Citi
07/15/21 RBC Capital
Fortescue Metals downgraded to Underperform from Sector Perform at RBC Capital
04/13/21 Goldman Sachs
Fortescue Metals downgraded to Sell from Neutral at Goldman Sachs
Downgrade
Mitsubishi Motors downgraded to Sell from Neutral at Citi » 06:44
12/01/21
12/01
06:44
12/01/21
06:44
MMTOF

Mitsubishi Motors

/

+

Citi analyst Arifumi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMTOF Mitsubishi Motors
/

+

07/28/21 CLSA
Mitsubishi Motors upgraded to Buy from Outperform at CLSA
Upgrade
Ardelyx upgraded to Buy at Ladenburg on IBS-C treatment launch plan » 06:44
12/01/21
12/01
06:44
12/01/21
06:44
ARDX

Ardelyx

$1.16 /

+0.2946 (+34.04%)

Ladenburg analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

06:32 Today Ladenburg
Ardelyx upgraded to Buy from Neutral at Ladenburg
06:28 Today Citi
Ardelyx price target raised to $13 from $7 at Citi
11/30/21 Citi
Ardelyx price target raised to $13 from $7 at Citi
11/30/21 Piper Sandler
Piper keeps Neutral on Ardelyx, says Ibsrela IBS-C launch seems like 'Hail Mary'
ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

Hot Stocks
Meta cryptocurrency head David Marcus to step down » 06:43
12/01/21
12/01
06:43
12/01/21
06:43
MVRS

Meta

/

+

, FB

Facebook; also tag MVRS

$324.30 /

-13.525 (-4.00%)

In a series of Tuesday…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MVRS Meta
/

+

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

MVRS Meta
/

+

11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

MVRS Meta
/

+

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

MVRS Meta
/

+

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

Earnings
Philip Morris cuts FY21 diluted EPS view to $5.74-$5.79 from $5.77-$5.82 » 06:43
12/01/21
12/01
06:43
12/01/21
06:43
PM

Philip Morris

$85.98 /

-1.37 (-1.57%)

FY21 consensus $6.08. PMI…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PM Philip Morris
$85.98 /

-1.37 (-1.57%)

PM Philip Morris
$85.98 /

-1.37 (-1.57%)

11/29/21 Barclays
Philip Morris price target lowered to $113 from $116 at Barclays
09/30/21 Stifel
Stifel surprised and 'disappointed' by ITC banning IQOS importation
09/30/21 BofA
Altria, Philip Morris still well positioned despite IQOS 'setback,' says BofA
09/13/21 Stifel
Altria could trade down on news of Democrats' proposal, says Stifel
PM Philip Morris
$85.98 /

-1.37 (-1.57%)

PM Philip Morris
$85.98 /

-1.37 (-1.57%)

PM Philip Morris
$85.98 /

-1.37 (-1.57%)

Downgrade
Hong Leong Bank downgraded to Neutral from Buy at Citi » 06:42
12/01/21
12/01
06:42
12/01/21
06:42
HLFAF

Hong Leong Bank

/

+

Citi analyst Robert Kong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
UnitedHealth price target raised to $452 from $435 at UBS » 06:42
12/01/21
12/01
06:42
12/01/21
06:42
UNH

UnitedHealth

$444.20 /

-7.75 (-1.71%)

UBS analyst Kavin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNH UnitedHealth
$444.20 /

-7.75 (-1.71%)

UNH UnitedHealth
$444.20 /

-7.75 (-1.71%)

11/16/21 Deutsche Bank
UnitedHealth price target raised to $477 from $421 at Deutsche Bank
11/11/21 Barclays
MultiPlan price target lowered to $6 from $7 at Barclays
11/10/21 Mizuho
UnitedHealth price target raised to $500 from $455 at Mizuho
11/03/21 Piper Sandler
Piper ups Tivity Health target to $27 after results, ahead of contract renewal
UNH UnitedHealth
$444.20 /

-7.75 (-1.71%)

UNH UnitedHealth
$444.20 /

-7.75 (-1.71%)

UNH UnitedHealth
$444.20 /

-7.75 (-1.71%)

UNH UnitedHealth
$444.20 /

-7.75 (-1.71%)

Upgrade
Gordon Haskett sees 'compelling re-entry point,' upgrades DoorDash to Buy » 06:39
12/01/21
12/01
06:39
12/01/21
06:39
DASH

DoorDash

$178.74 /

-4.22 (-2.31%)

Gordon Haskett analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DASH DoorDash
$178.74 /

-4.22 (-2.31%)

DASH DoorDash
$178.74 /

-4.22 (-2.31%)

06:04 Today Gordon Haskett
DoorDash upgraded to Buy from Hold at Gordon Haskett
11/22/21 KGI Securities
DoorDash upgraded to Outperform from Neutral at KGI Securities
11/18/21 Morgan Stanley
Uber One subscription offering well positioned versus peers, says Morgan Stanley
11/11/21 DA Davidson
DoorDash price target raised to $210 from $158 at DA Davidson
DASH DoorDash
$178.74 /

-4.22 (-2.31%)

  • 19
    Aug
  • 20
    May
  • 09
    Dec
DASH DoorDash
$178.74 /

-4.22 (-2.31%)

DASH DoorDash
$178.74 /

-4.22 (-2.31%)

DASH DoorDash
$178.74 /

-4.22 (-2.31%)

Hot Stocks
Bionano Genomics CEO buys 5K shares of common stock » 06:38
12/01/21
12/01
06:38
12/01/21
06:38
BNGO

Bionano Genomics

$3.91 /

-0.015 (-0.38%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNGO Bionano Genomics
$3.91 /

-0.015 (-0.38%)

BNGO Bionano Genomics
$3.91 /

-0.015 (-0.38%)

06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
BNGO Bionano Genomics
$3.91 /

-0.015 (-0.38%)

  • 20
    Jan
  • 08
    Jan
BNGO Bionano Genomics
$3.91 /

-0.015 (-0.38%)

Upgrade
Alsea upgraded to Buy from Neutral at Citi » 06:37
12/01/21
12/01
06:37
12/01/21
06:37
ALSSF

Alsea

$1.72 /

-0.0671 (-3.75%)

Citi analyst Sergio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALSSF Alsea
$1.72 /

-0.0671 (-3.75%)

07/02/21
Fly Intel: Top five analyst upgrades
07/02/21 JPMorgan
Alsea upgraded to Neutral from Underweight at JPMorgan
04/22/21 Goldman Sachs
Alsea initiated with a Sell at Goldman Sachs
01/19/21 Barclays
Alsea upgraded to Overweight from Equal Weight at Barclays
Initiation
Alkermes initiated with a Neutral at Citi » 06:35
12/01/21
12/01
06:35
12/01/21
06:35
ALKS

Alkermes

$21.93 /

-0.495 (-2.21%)

Citi analyst Navann Ty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALKS Alkermes
$21.93 /

-0.495 (-2.21%)

ALKS Alkermes
$21.93 /

-0.495 (-2.21%)

11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
10/28/21 Mizuho
Alkermes shares have 25% upside after selloff, says Mizuho
10/28/21 H.C. Wainwright
Alkermes price target raised to $30 from $25 at H.C. Wainwright
10/27/21 Stifel
Alkermes price target raised to $29 from $25 at Stifel
ALKS Alkermes
$21.93 /

-0.495 (-2.21%)

ALKS Alkermes
$21.93 /

-0.495 (-2.21%)

Hot Stocks
Macau reports November casino revenue up 0.01% to 6.75B patacas » 06:34
12/01/21
12/01
06:34
12/01/21
06:34
LVS

Las Vegas Sands

$35.62 /

-1.63 (-4.38%)

, MGM

MGM Resorts

$39.59 /

-1.54 (-3.74%)

, WYNN

Wynn Resorts

$81.12 /

-1.83 (-2.21%)

, MLCO

Melco Resorts & Entertainment

$9.77 /

-0.33 (-3.27%)

Macau's gaming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVS Las Vegas Sands
$35.62 /

-1.63 (-4.38%)

MGM MGM Resorts
$39.59 /

-1.54 (-3.74%)

WYNN Wynn Resorts
$81.12 /

-1.83 (-2.21%)

MLCO Melco Resorts & Entertainment
$9.77 /

-0.33 (-3.27%)

LVS Las Vegas Sands
$35.62 /

-1.63 (-4.38%)

10/21/21 Credit Suisse
Las Vegas Sands price target lowered to $60 from $69 at Credit Suisse
10/21/21 Wells Fargo
Las Vegas Sands price target lowered to $42 from $50 at Wells Fargo
10/21/21 Stifel
Las Vegas Sands should 'take a stand' with 'aggressive' buybacks, says Stifel
10/21/21 Citi
Las Vegas Sands price target lowered to $58.50 from $61 at Citi
MGM MGM Resorts
$39.59 /

-1.54 (-3.74%)

11/23/21 Morgan Stanley
MGM Resorts resumed with an Equal Weight at Morgan Stanley
11/04/21 Stifel
MGM Resorts price target raised to $54 from $45 at Stifel
11/04/21 Wells Fargo
MGM Resorts price target raised to $62 from $55 at Wells Fargo
10/19/21 Craig-Hallum
Penn, Rush Street share solid despite 'disciplined spend,' says Craig-Hallum
WYNN Wynn Resorts
$81.12 /

-1.83 (-2.21%)

11/10/21 Wells Fargo
Wynn Resorts price target lowered to $101 from $112 at Wells Fargo
11/10/21 Deutsche Bank
Wynn Resorts price target lowered to $131 from $140 at Deutsche Bank
11/10/21 Stifel
Wynn Resorts price target raised to $124 from $107 at Stifel
10/20/21 Morgan Stanley
Wynn Resorts price target lowered to $107 from $113 at Morgan Stanley
MLCO Melco Resorts & Entertainment
$9.77 /

-0.33 (-3.27%)

11/26/21 Credit Suisse
Credit Suisse upgrades Macau stocks with 'light at the end of the tunnel'
11/24/21 Credit Suisse
Melco Resorts upgraded to Outperform from Underperform at Credit Suisse
09/28/21 Citi
Melco Resorts price target lowered to $14.50 from $24.50 at Citi
09/24/21 Credit Suisse
As Macau locks down, Credit Suisse warns of downside risk to 2022 GGR estimates
LVS Las Vegas Sands
$35.62 /

-1.63 (-4.38%)

MGM MGM Resorts
$39.59 /

-1.54 (-3.74%)

WYNN Wynn Resorts
$81.12 /

-1.83 (-2.21%)

MLCO Melco Resorts & Entertainment
$9.77 /

-0.33 (-3.27%)

  • 09
    Feb
LVS Las Vegas Sands
$35.62 /

-1.63 (-4.38%)

MGM MGM Resorts
$39.59 /

-1.54 (-3.74%)

WYNN Wynn Resorts
$81.12 /

-1.83 (-2.21%)

MLCO Melco Resorts & Entertainment
$9.77 /

-0.33 (-3.27%)

LVS Las Vegas Sands
$35.62 /

-1.63 (-4.38%)

MGM MGM Resorts
$39.59 /

-1.54 (-3.74%)

WYNN Wynn Resorts
$81.12 /

-1.83 (-2.21%)

MLCO Melco Resorts & Entertainment
$9.77 /

-0.33 (-3.27%)

LVS Las Vegas Sands
$35.62 /

-1.63 (-4.38%)

MGM MGM Resorts
$39.59 /

-1.54 (-3.74%)

WYNN Wynn Resorts
$81.12 /

-1.83 (-2.21%)

MLCO Melco Resorts & Entertainment
$9.77 /

-0.33 (-3.27%)

Hot Stocks
Sage Therapeutics and Biogen report positive data on depression disorder drug » 06:34
12/01/21
12/01
06:34
12/01/21
06:34
SAGE

Sage Therapeutics

$38.85 /

+0.24 (+0.62%)

, BIIB

Biogen

$235.67 /

-0.68 (-0.29%)

Sage Therapeutics (SAGE)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$38.85 /

+0.24 (+0.62%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

SAGE Sage Therapeutics
$38.85 /

+0.24 (+0.62%)

11/18/21 Mizuho
Sage Therapeutics price target lowered to $44 from $52 at Mizuho
11/03/21 H.C. Wainwright
Sage Therapeutics price target lowered to $55 from $80 at H.C. Wainwright
11/02/21 RBC Capital
Sage Therapeutics price target lowered to $48 from $52 at RBC Capital
11/02/21 Piper Sandler
Sage's change to CORAL trial increases odds of approval, says Piper Sandler
BIIB Biogen
$235.67 /

-0.68 (-0.29%)

11/30/21 Wedbush
Wedbush keeps Neutral rating on Biogen after court denies appeal in patent case
11/18/21 BMO Capital
Biogen initiated with an Outperform at BMO Capital
11/17/21 Cowen
Cowen says Biogen negative vote at CHMP 'disappointing, but far from surprising'
11/17/21 Stifel
Biogen shares weren't really pricing in Europe approval, says Stifel
SAGE Sage Therapeutics
$38.85 /

+0.24 (+0.62%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

SAGE Sage Therapeutics
$38.85 /

+0.24 (+0.62%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

Recommendations
Omnicell price target raised to $220 from $210 at BTIG » 06:33
12/01/21
12/01
06:33
12/01/21
06:33
OMCL

Omnicell

$177.11 /

-0.06 (-0.03%)

BTIG analyst David Larsen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMCL Omnicell
$177.11 /

-0.06 (-0.03%)

OMCL Omnicell
$177.11 /

-0.06 (-0.03%)

11/03/21 Craig-Hallum
Omnicell price target raised to $205 from $170 at Craig-Hallum
11/03/21 Piper Sandler
Omnicell price target raised to $211 from $188 at Piper Sandler
10/26/21 BTIG
Omnicell price target raised to $200 from $175 at BTIG
07/30/21 Benchmark
Omnicell should be bought on post-earnings weakness, says Benchmark
OMCL Omnicell
$177.11 /

-0.06 (-0.03%)

Hot Stocks
Ault Global Holdings' BitNile sees annualized run rate of 287.6 Bitcoin » 06:32
12/01/21
12/01
06:32
12/01/21
06:32
DPW

Ault Global Holdings

$1.77 /

-0.03 (-1.67%)

Ault Global Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DPW Ault Global Holdings
$1.77 /

-0.03 (-1.67%)

DPW Ault Global Holdings
$1.77 /

-0.03 (-1.67%)

DPW Ault Global Holdings
$1.77 /

-0.03 (-1.67%)

Upgrade
Ardelyx upgraded to Buy from Neutral at Ladenburg » 06:32
12/01/21
12/01
06:32
12/01/21
06:32
ARDX

Ardelyx

$1.16 /

+0.2946 (+34.04%)

Ladenburg analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

06:28 Today Citi
Ardelyx price target raised to $13 from $7 at Citi
11/30/21 Citi
Ardelyx price target raised to $13 from $7 at Citi
11/30/21 Piper Sandler
Piper keeps Neutral on Ardelyx, says Ibsrela IBS-C launch seems like 'Hail Mary'
10/14/21 Ladenburg
Ardelyx downgraded to Neutral from Buy at Ladenburg
ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

Recommendations
Freshpet sales tracking below full year target, says Citi » 06:32
12/01/21
12/01
06:32
12/01/21
06:32
FRPT

Freshpet

$108.05 /

-0.57 (-0.52%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$108.05 /

-0.57 (-0.52%)

FRPT Freshpet
$108.05 /

-0.57 (-0.52%)

11/09/21 Baird
Freshpet price target lowered to $185 from $210 at Baird
11/09/21 Citi
Freshpet price target lowered to $120 from $123 at Citi
10/13/21
Fly Intel: Top five analyst upgrades
10/13/21 Truist
Truist upgrades Freshpet to Buy ahead of its 'next chapter' of expanded output
FRPT Freshpet
$108.05 /

-0.57 (-0.52%)

  • 24
    Feb
FRPT Freshpet
$108.05 /

-0.57 (-0.52%)

Recommendations
Zscaler price target raised to $439 from $401 at BTIG » 06:30
12/01/21
12/01
06:30
12/01/21
06:30
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

BTIG analyst Gray Powell…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

06:14 Today JMP Securities
Zscaler price target raised to $400 from $330 at JMP Securities
06:03 Today Piper Sandler
Zscaler price target raised to $365 from $285 at Piper Sandler
11/29/21 Needham
Zscaler price target raised to $390 from $345 at Needham
11/29/21 RBC Capital
Zscaler price target raised to $380 from $326 at RBC Capital
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

General news
European stock markets are broadly higher, » 06:30
12/01/21
12/01
06:30
12/01/21
06:30
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Recommendations
Applied Materials price target raised to $175 from $160 at Citi » 06:29
12/01/21
12/01
06:29
12/01/21
06:29
AMAT

Applied Materials

$147.09 /

-4.32 (-2.85%)

Citi analyst Atif Malik…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMAT Applied Materials
$147.09 /

-4.32 (-2.85%)

AMAT Applied Materials
$147.09 /

-4.32 (-2.85%)

11/23/21 Lynx
Applied Materials price target raised to $200 from $140 at Lynx
11/19/21 DA Davidson
Applied Materials price target raised to $175 from $165 at DA Davidson
11/19/21 Deutsche Bank
Applied Materials price target raised to $170 from $160 at Deutsche Bank
11/11/21 Wells Fargo
Applied Materials price target raised to $175 from $160 at Wells Fargo
AMAT Applied Materials
$147.09 /

-4.32 (-2.85%)

AMAT Applied Materials
$147.09 /

-4.32 (-2.85%)

AMAT Applied Materials
$147.09 /

-4.32 (-2.85%)

Recommendations
Ardelyx price target raised to $13 from $7 at Citi » 06:28
12/01/21
12/01
06:28
12/01/21
06:28
ARDX

Ardelyx

$1.16 /

+0.2946 (+34.04%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

11/30/21 Citi
Ardelyx price target raised to $13 from $7 at Citi
11/30/21 Piper Sandler
Piper keeps Neutral on Ardelyx, says Ibsrela IBS-C launch seems like 'Hail Mary'
10/14/21 Ladenburg
Ardelyx downgraded to Neutral from Buy at Ladenburg
10/14/21 Ladenburg
Ardelyx downgraded to Neutral from Buy at Ladenburg
ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

ARDX Ardelyx
$1.16 /

+0.2946 (+34.04%)

Recommendations
Genius Sports price target lowered to $13 from $22 at Citi » 06:27
12/01/21
12/01
06:27
12/01/21
06:27
GENI

Genius Sports

$9.52 /

-0.49 (-4.90%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GENI Genius Sports
$9.52 /

-0.49 (-4.90%)

GENI Genius Sports
$9.52 /

-0.49 (-4.90%)

11/24/21 Needham
Genius Sports price target lowered to $22 from $29 at Needham
11/24/21 B. Riley
Genius Sports price target lowered to $23 from $32 at B. Riley
11/24/21 Craig-Hallum
Genius Sports price target lowered to $27 from $32 at Craig-Hallum
11/24/21 Benchmark
Genius Sports price target lowered to $20 from $33 at Benchmark
GENI Genius Sports
$9.52 /

-0.49 (-4.90%)

  • 10
    Jun
GENI Genius Sports
$9.52 /

-0.49 (-4.90%)

GENI Genius Sports
$9.52 /

-0.49 (-4.90%)

GENI Genius Sports
$9.52 /

-0.49 (-4.90%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.